The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Prostaglandin D2 Receptor 2 Market Research Report 2024
Synopsis
The global Prostaglandin D2 Receptor 2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostaglandin D2 Receptor 2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostaglandin D2 Receptor 2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prostaglandin D2 Receptor 2 include Allergan Plc, Brickell Biotech, Inc., Ligand Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Oxagen Limited, Panmira Pharmaceuticals, LLC., Pulmagen Therapeutics LLP and Taisho Pharmaceutical Holdings Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin D2 Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin D2 Receptor 2.
Report Scope
The Prostaglandin D2 Receptor 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin D2 Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin D2 Receptor 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc
Brickell Biotech, Inc.
Ligand Pharmaceuticals, Inc.
Merck & Co., Inc.
Novartis AG
Oxagen Limited
Panmira Pharmaceuticals, LLC.
Pulmagen Therapeutics LLP
Taisho Pharmaceutical Holdings Co., Ltd.
Segment by Type
OC-2417
MK-1029
BBI-5000
ADC-7405
Others
Segment by Application
Atopic Dermatitis
Allergic Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostaglandin D2 Receptor 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Prostaglandin D2 Receptor 2 market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Prostaglandin D2 Receptor 2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Prostaglandin D2 Receptor 2 is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Prostaglandin D2 Receptor 2 include Allergan Plc, Brickell Biotech, Inc., Ligand Pharmaceuticals, Inc., Merck & Co., Inc., Novartis AG, Oxagen Limited, Panmira Pharmaceuticals, LLC., Pulmagen Therapeutics LLP and Taisho Pharmaceutical Holdings Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Prostaglandin D2 Receptor 2, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prostaglandin D2 Receptor 2.
Report Scope
The Prostaglandin D2 Receptor 2 market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Prostaglandin D2 Receptor 2 market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prostaglandin D2 Receptor 2 manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Allergan Plc
Brickell Biotech, Inc.
Ligand Pharmaceuticals, Inc.
Merck & Co., Inc.
Novartis AG
Oxagen Limited
Panmira Pharmaceuticals, LLC.
Pulmagen Therapeutics LLP
Taisho Pharmaceutical Holdings Co., Ltd.
Segment by Type
OC-2417
MK-1029
BBI-5000
ADC-7405
Others
Segment by Application
Atopic Dermatitis
Allergic Asthma
Chronic Obstructive Pulmonary Disease
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prostaglandin D2 Receptor 2 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prostaglandin D2 Receptor 2 in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Prostaglandin D2 Receptor 2 Market Overview
1.1 Product Overview and Scope of Prostaglandin D2 Receptor 2
1.2 Prostaglandin D2 Receptor 2 Segment by Type
1.2.1 Global Prostaglandin D2 Receptor 2 Market Value Comparison by Type (2024-2030)
1.2.2 OC-2417
1.2.3 MK-1029
1.2.4 BBI-5000
1.2.5 ADC-7405
1.2.6 Others
1.3 Prostaglandin D2 Receptor 2 Segment by Application
1.3.1 Global Prostaglandin D2 Receptor 2 Market Value by Application: (2024-2030)
1.3.2 Atopic Dermatitis
1.3.3 Allergic Asthma
1.3.4 Chronic Obstructive Pulmonary Disease
1.3.5 Others
1.4 Global Prostaglandin D2 Receptor 2 Market Size Estimates and Forecasts
1.4.1 Global Prostaglandin D2 Receptor 2 Revenue 2019-2030
1.4.2 Global Prostaglandin D2 Receptor 2 Sales 2019-2030
1.4.3 Global Prostaglandin D2 Receptor 2 Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Prostaglandin D2 Receptor 2 Market Competition by Manufacturers
2.1 Global Prostaglandin D2 Receptor 2 Sales Market Share by Manufacturers (2019-2024)
2.2 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Prostaglandin D2 Receptor 2 Average Price by Manufacturers (2019-2024)
2.4 Global Prostaglandin D2 Receptor 2 Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prostaglandin D2 Receptor 2, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prostaglandin D2 Receptor 2, Product Type & Application
2.7 Prostaglandin D2 Receptor 2 Market Competitive Situation and Trends
2.7.1 Prostaglandin D2 Receptor 2 Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prostaglandin D2 Receptor 2 Players Market Share by Revenue
2.7.3 Global Prostaglandin D2 Receptor 2 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prostaglandin D2 Receptor 2 Retrospective Market Scenario by Region
3.1 Global Prostaglandin D2 Receptor 2 Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Prostaglandin D2 Receptor 2 Global Prostaglandin D2 Receptor 2 Sales by Region: 2019-2030
3.2.1 Global Prostaglandin D2 Receptor 2 Sales by Region: 2019-2024
3.2.2 Global Prostaglandin D2 Receptor 2 Sales by Region: 2025-2030
3.3 Global Prostaglandin D2 Receptor 2 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2019-2030
3.3.1 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2019-2024
3.3.2 Global Prostaglandin D2 Receptor 2 Revenue by Region: 2025-2030
3.4 North America Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
3.4.1 North America Prostaglandin D2 Receptor 2 Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Prostaglandin D2 Receptor 2 Sales by Country (2019-2030)
3.4.3 North America Prostaglandin D2 Receptor 2 Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
3.5.1 Europe Prostaglandin D2 Receptor 2 Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Prostaglandin D2 Receptor 2 Sales by Country (2019-2030)
3.5.3 Europe Prostaglandin D2 Receptor 2 Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
3.6.1 Asia Pacific Prostaglandin D2 Receptor 2 Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Prostaglandin D2 Receptor 2 Sales by Country (2019-2030)
3.6.3 Asia Pacific Prostaglandin D2 Receptor 2 Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
3.7.1 Latin America Prostaglandin D2 Receptor 2 Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Prostaglandin D2 Receptor 2 Sales by Country (2019-2030)
3.7.3 Latin America Prostaglandin D2 Receptor 2 Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prostaglandin D2 Receptor 2 Market Facts & Figures by Country
3.8.1 Middle East and Africa Prostaglandin D2 Receptor 2 Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Prostaglandin D2 Receptor 2 Sales by Country (2019-2030)
3.8.3 Middle East and Africa Prostaglandin D2 Receptor 2 Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2019-2030)
4.1.1 Global Prostaglandin D2 Receptor 2 Sales by Type (2019-2024)
4.1.2 Global Prostaglandin D2 Receptor 2 Sales by Type (2025-2030)
4.1.3 Global Prostaglandin D2 Receptor 2 Sales Market Share by Type (2019-2030)
4.2 Global Prostaglandin D2 Receptor 2 Revenue by Type (2019-2030)
4.2.1 Global Prostaglandin D2 Receptor 2 Revenue by Type (2019-2024)
4.2.2 Global Prostaglandin D2 Receptor 2 Revenue by Type (2025-2030)
4.2.3 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Type (2019-2030)
4.3 Global Prostaglandin D2 Receptor 2 Price by Type (2019-2030)
5 Segment by Application
5.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2019-2030)
5.1.1 Global Prostaglandin D2 Receptor 2 Sales by Application (2019-2024)
5.1.2 Global Prostaglandin D2 Receptor 2 Sales by Application (2025-2030)
5.1.3 Global Prostaglandin D2 Receptor 2 Sales Market Share by Application (2019-2030)
5.2 Global Prostaglandin D2 Receptor 2 Revenue by Application (2019-2030)
5.2.1 Global Prostaglandin D2 Receptor 2 Revenue by Application (2019-2024)
5.2.2 Global Prostaglandin D2 Receptor 2 Revenue by Application (2025-2030)
5.2.3 Global Prostaglandin D2 Receptor 2 Revenue Market Share by Application (2019-2030)
5.3 Global Prostaglandin D2 Receptor 2 Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Allergan Plc
6.1.1 Allergan Plc Corporation Information
6.1.2 Allergan Plc Description and Business Overview
6.1.3 Allergan Plc Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Allergan Plc Prostaglandin D2 Receptor 2 Product Portfolio
6.1.5 Allergan Plc Recent Developments/Updates
6.2 Brickell Biotech, Inc.
6.2.1 Brickell Biotech, Inc. Corporation Information
6.2.2 Brickell Biotech, Inc. Description and Business Overview
6.2.3 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Brickell Biotech, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
6.2.5 Brickell Biotech, Inc. Recent Developments/Updates
6.3 Ligand Pharmaceuticals, Inc.
6.3.1 Ligand Pharmaceuticals, Inc. Corporation Information
6.3.2 Ligand Pharmaceuticals, Inc. Description and Business Overview
6.3.3 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Ligand Pharmaceuticals, Inc. Prostaglandin D2 Receptor 2 Product Portfolio
6.3.5 Ligand Pharmaceuticals, Inc. Recent Developments/Updates
6.4 Merck & Co., Inc.
6.4.1 Merck & Co., Inc. Corporation Information
6.4.2 Merck & Co., Inc. Description and Business Overview
6.4.3 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Merck & Co., Inc. Prostaglandin D2 Receptor 2 Product Portfolio
6.4.5 Merck & Co., Inc. Recent Developments/Updates
6.5 Novartis AG
6.5.1 Novartis AG Corporation Information
6.5.2 Novartis AG Description and Business Overview
6.5.3 Novartis AG Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Novartis AG Prostaglandin D2 Receptor 2 Product Portfolio
6.5.5 Novartis AG Recent Developments/Updates
6.6 Oxagen Limited
6.6.1 Oxagen Limited Corporation Information
6.6.2 Oxagen Limited Description and Business Overview
6.6.3 Oxagen Limited Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Oxagen Limited Prostaglandin D2 Receptor 2 Product Portfolio
6.6.5 Oxagen Limited Recent Developments/Updates
6.7 Panmira Pharmaceuticals, LLC.
6.6.1 Panmira Pharmaceuticals, LLC. Corporation Information
6.6.2 Panmira Pharmaceuticals, LLC. Description and Business Overview
6.6.3 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Panmira Pharmaceuticals, LLC. Prostaglandin D2 Receptor 2 Product Portfolio
6.7.5 Panmira Pharmaceuticals, LLC. Recent Developments/Updates
6.8 Pulmagen Therapeutics LLP
6.8.1 Pulmagen Therapeutics LLP Corporation Information
6.8.2 Pulmagen Therapeutics LLP Description and Business Overview
6.8.3 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Pulmagen Therapeutics LLP Prostaglandin D2 Receptor 2 Product Portfolio
6.8.5 Pulmagen Therapeutics LLP Recent Developments/Updates
6.9 Taisho Pharmaceutical Holdings Co., Ltd.
6.9.1 Taisho Pharmaceutical Holdings Co., Ltd. Corporation Information
6.9.2 Taisho Pharmaceutical Holdings Co., Ltd. Description and Business Overview
6.9.3 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Taisho Pharmaceutical Holdings Co., Ltd. Prostaglandin D2 Receptor 2 Product Portfolio
6.9.5 Taisho Pharmaceutical Holdings Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prostaglandin D2 Receptor 2 Industry Chain Analysis
7.2 Prostaglandin D2 Receptor 2 Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prostaglandin D2 Receptor 2 Production Mode & Process
7.4 Prostaglandin D2 Receptor 2 Sales and Marketing
7.4.1 Prostaglandin D2 Receptor 2 Sales Channels
7.4.2 Prostaglandin D2 Receptor 2 Distributors
7.5 Prostaglandin D2 Receptor 2 Customers
8 Prostaglandin D2 Receptor 2 Market Dynamics
8.1 Prostaglandin D2 Receptor 2 Industry Trends
8.2 Prostaglandin D2 Receptor 2 Market Drivers
8.3 Prostaglandin D2 Receptor 2 Market Challenges
8.4 Prostaglandin D2 Receptor 2 Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
